3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
50
Prostatic Neoplasms
23
Lung Neoplasms
17
Breast Neoplasms
16
Squamous Cell Carcinoma of Head and Neck
13
Neoplasms
9
Stomach Neoplasms
8
Parkinson Disease 4, Autosomal Dominant Lewy Body
6
Neoplasm Metastasis
6
Head and Neck Neoplasms
6
Carcinoma, Transitional Cell
6
Urinary Bladder Neoplasms
5
Triple Negative Breast Neoplasms
5
Non-Muscle Invasive Bladder Neoplasms
5
Endometrial Neoplasms
5
Carcinoma, Squamous Cell
5
Prostatic Neoplasms, Castration-Resistant
4
Oropharyngeal Neoplasms
4
Small Cell Lung Carcinoma
3
Ovarian Neoplasms
3
Nasopharyngeal Carcinoma
3
HER2-positive Breast Cancer
3
Esophageal Squamous Cell Carcinoma
3
Carcinoma
3
Anatomic Stage I Breast Cancer AJCC v8
3
Adenocarcinoma
3
Vaccinia
2
Solid Tumors
2
Sarcoma
2
Salivary Gland Neoplasms
2
Interventions
pembrolizumab
6
avelumab
6
Nivolumab
5
Specimen Handling
4
Magnetic Resonance Spectroscopy
3
Biopsy
3
prednylidene
2
lutetium Lu 177 dotatate
2
deltacortene
2
Prednisone
2
Ipilimumab
2
CTLA-4 Antigen
2
talimogene laherparepvec
1
lenvatinib
1
fludarabine phosphate
1
fludarabine
1
decitabine and cedazuridine drug combination
1
cemiplimab
1
aldesleukin
1
Tacrolimus
1
Sirolimus
1
Saline Solution
1
Radiotherapy
1
Radiosurgery
1
MAPRE1 protein, human
1
Lutetium-177
1
Laparoscopy
1
Exercise Test
1
Cyclophosphamide
1
Axitinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Carcinoma, Merkel Cell
×
Docetaxel
×
90 days
×
Clear all
No trials found.